Key Companies Covered in the Global Myasthenia Gravis (MG) Disease Market Research Report by Kenneth Research are Alexion Pharamaceuticals, Inc., AbbVie.
UCB, a global biopharmaceutical company, today announced results from two Phase 3 studies evaluating its investigational treatments, zilucoplan, a self-administered, subcutaneous (SC) peptide inhibitor of complement component 5 (C5 inhibitor) and rozanolixizumab, an SC-infused monoclonal antibody targeting the .
FDA approves Alexion s Ultomiris for generalised myasthenia gravis pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.
A little over two weeks after revealing her fibromyalgia diagnosis, the former star of Teen Mom 2 is rushed to a hospital after suffering from mysterious chest pain.